The Wuhan SARS‐CoV‐2—What's next for China

Saved in:
Bibliographic Details
Published inJournal of medical virology Vol. 92; no. 6; pp. 546 - 547
Main Authors Lu, Hongzhou, Stratton, Charles W., Tang, Yi‐Wei
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.06.2020
John Wiley and Sons Inc
Subjects
Antiviral Agents - chemical synthesis
Antiviral Agents - therapeutic use
Betacoronavirus - drug effects
Betacoronavirus - genetics
Betacoronavirus - pathogenicity
China - epidemiology
Communicable Disease Control - organization & administration
Coronavirus Infections - diagnosis
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Coronavirus Infections - therapy
Coronavirus Infections - transmission
COVID-19
COVID-19 Vaccines
Disease Management
Disease Outbreaks
Humans
Pandemics
Pneumonia, Viral - diagnosis
Pneumonia, Viral - epidemiology
Pneumonia, Viral - therapy
Pneumonia, Viral - transmission
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Travel - statistics & numerical data
Viral Vaccines - biosynthesis
Virology
China
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0146-6615
1096-9071
1096-9071
DOI:10.1002/jmv.25738